Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

Genetic testing of pancreatic cancer tumors may improve treatment


But new research suggests that identifying the genetics of pancreatic cancer in individual patients could boost survival for some. (UPI Latest News) More More

Similar stories

3 Cancer Treatment Stocks to Buy in March - Motley Fool

3 Cancer Treatment Stocks to Buy in March  Motley Fool

There has been tremendous progress in the battle against cancer, but it remains the second leading cause of death in the U.S., behind heart disease.

Posted on 23 March 2019 | 11:14 am | Google News

News digest – hot tea, cancer doctor shortages, junk food ad ban proposals and baby Grady - Cancer Research UK

News digest – hot tea, cancer doctor shortages, junk food ad ban proposals and baby Grady  Cancer Research UK

In this week's news: headlines saying 'hot tea causes oesophageal cancer' miss crucial details and Government proposes junk food ad watershed.

Posted on 23 March 2019 | 2:04 am | Google News

TrovaGene Inc. (TROV)'s Financial Results Comparing With Anixa Biosciences Inc. (NASDAQ:ANIX) - Port Courier

TrovaGene Inc. (TROV)'s Financial Results Comparing With Anixa Biosciences Inc. (NASDAQ:ANIX)  Port Courier

This is therefore a contrasting of the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation in TrovaGene Inc.

Posted on 22 March 2019 | 2:27 pm | Google News

Lynch Syndrome and Pancreatic Cancer Risk - Pancreatic Cancer News & Stories

Lynch Syndrome and Pancreatic Cancer Risk  Pancreatic Cancer News & Stories

Find out how Lynch syndrome can increase a person's risk of developing pancreatic cancer and other cancer types, and how having Lynch syndrome can ...

Posted on 22 March 2019 | 8:00 am | Google News

Abbott Laboratories (ABT) to pay $0.32 on May 15, 2019; TrovaGene, Inc. (TROV) Covered By 2 Bullish Analysts Last Week - Thе Mоnіtоr

Abbott Laboratories (ABT) to pay $0.32 on May 15, 2019; TrovaGene, Inc. (TROV) Covered By 2 Bullish Analysts Last Week  Thе Mоnіtоr

Abbott Laboratories (NYSE:ABT) is expected to pay $0.32 on May 15, 2019. (NYSE:ABT) shareholders before Apr 12, 2019 will receive the $0.32 dividend.

Posted on 22 March 2019 | 6:21 am | Google News

Genetic testing can detect melanoma earlier, but tailored approach is required - Healio

Genetic testing can detect melanoma earlier, but tailored approach is required  Healio

Genetic testing can help increase early detection of melanoma among patients and their family members, according to a presenter at HemOnc Today New York.

Posted on 21 March 2019 | 5:46 pm | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info